Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 10/31/2025
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 271 publications
Effective management of psoriasis and psoriatic arthritis in a patient with systemic lupus erythematosus using deucravacitinib, mycophenolate mofetil and hydroxychloroquine.
Journal: Skin health and disease
Published: October 02, 2025
A real world study on the effectiveness and safety of deu-cravacitinib in the treatment of moderate to severe plaque psoriasis in China
Journal: Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences
Published: September 30, 2025
Review of Promising Off-Label Use of Deucravacitinib.
Journal: International journal of molecular sciences
Published: August 24, 2025
Comparative Efficacy of Deucravacitinib and Adalimumab for Scalp Psoriasis: An Indirect Treatment Comparison.
Journal: Journal of drugs in dermatology : JDD
Published: August 07, 2025
Deucravacitinib With Add-On Calcipotriene/Betamethasone Dipropionate for Treating Moderate to Severe Plaque Psoriasis.
Journal: Journal of drugs in dermatology : JDD
Published: August 07, 2025
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Journal: The Cochrane database of systematic reviews
Published: August 06, 2025
Management of Erythrodermic Psoriasis with Systemic Therapies: A Systematic Review.
Journal: American journal of clinical dermatology
Published: July 30, 2025
Successful treatment of recalcitrant amyopathic dermatomyositis with deucravacitinib in addition to intravenous immunoglobulin.
Journal: JAAD case reports
Published: July 11, 2025
Efficacy and Safety of Biologics for Systemic Lupus Erythematosus (SLE): A Systematic Review and Network Meta-Analysis.
Journal: Clinical reviews in allergy & immunology
Published: July 11, 2025
Treatment of Lichen Planopilaris with the TYK-2 Inhibitor Deucravacitinib.
Journal: Journal of the American Academy of Dermatology
Published: July 09, 2025
Once-daily oral icotrokinra versus placebo and once-daily oral deucravacitinib in participants with moderate-to-severe plaque psoriasis (ICONIC-ADVANCE 1 & 2): two phase 3, randomised, placebo-controlled and active-comparator-controlled trials.
Journal: Lancet (London, England)
Published: July 08, 2025
Psoriasis: an update on topical and systemic therapies.
Journal: Australian prescriber
Published: June 26, 2025
Last Updated: 10/31/2025